A pioneering blood test designed to screen for more than 50 types of cancer, currently being evaluated by the NHS, has correctly identified the disease in nearly two-thirds of cases it flagged.
The Galleri test, which could be administered annually, detects DNA fragments shed by cancer cells in the bloodstream, often indicating disease before symptoms appear.
